메뉴 건너뛰기




Volumn 14, Issue 7, 2012, Pages 919-930

Reevaluating the imaging definition of tumor progression: Perfusion MRI quantifies recurrent glioblastoma tumor fraction, pseudoprogression, and radiation necrosis to predict survival

Author keywords

glioblastoma; histologic tumor fraction; perfusion MRI; pseudoprogression; radiation necrosis; recurrent; relative cerebral blood volume; survival

Indexed keywords

GADOBENATE DIMEGLUMINE; GADODIAMIDE;

EID: 84862856776     PISSN: 15228517     EISSN: 15235866     Source Type: Journal    
DOI: 10.1093/neuonc/nos112     Document Type: Article
Times cited : (180)

References (35)
  • 1
    • 0036787219 scopus 로고    scopus 로고
    • Toward better early-phase brain tumor clinical trials: A reappraisal of current methods and proposals for future strategies
    • Lang FF, Gilbert MR, Puduvalli VK, et al. Toward better early-phase brain tumor clinical trials: a reappraisal of current methods and proposals for future strategies. Neuro Oncol. 2002;4(4):268-277.
    • (2002) Neuro Oncol , vol.4 , Issue.4 , pp. 268-277
    • Lang, F.F.1    Gilbert, M.R.2    Puduvalli, V.K.3
  • 2
    • 77952317096 scopus 로고    scopus 로고
    • Six-month progression-free survival as an alternative primary efficacy endpoint to overall survival in newly diagnosed glioblastoma patients receiving temozolomide
    • Polley MY, Lamborn KR, Chang SM, et al. Six-month progression-free survival as an alternative primary efficacy endpoint to overall survival in newly diagnosed glioblastoma patients receiving temozolomide. Neuro Oncol. 2010;12(3):274-282.
    • (2010) Neuro Oncol. , vol.12 , Issue.3 , pp. 274-282
    • Polley, M.Y.1    Lamborn, K.R.2    Chang, S.M.3
  • 3
    • 34047238978 scopus 로고    scopus 로고
    • The relationship between six-month progression-free survival and 12-month overall survival end points for phase II trials in patients with glioblastoma multiforme
    • DOI 10.1215/15228517-2006-025
    • Ballman KV, Buckner JC, Brown PD, et al. The relationship between sixmonth progression-free survival and 12-month overall survival end points for phase II trials in patients with glioblastoma multiforme. Neuro Oncol. 2007;9(1):29-38. (Pubitemid 46543486)
    • (2007) Neuro-Oncology , vol.9 , Issue.1 , pp. 29-38
    • Ballman, K.V.1    Buckner, J.C.2    Brown, P.D.3    Giannini, C.4    Flynn, P.J.5    LaPlant, B.R.6    Jaeckle, K.A.7
  • 6
    • 77951625266 scopus 로고    scopus 로고
    • Updated response assessment criteria for high-grade gliomas: Response assessment in neuro-oncology working group
    • Wen PY, Macdonald DR, Reardon DA, et al. Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group. J Clin Oncol. 2010;28(11):1963-1972.
    • (2010) J Clin Oncol. , vol.28 , Issue.11 , pp. 1963-1972
    • Wen, P.Y.1    MacDonald, D.R.2    Reardon, D.A.3
  • 7
    • 64649085454 scopus 로고    scopus 로고
    • Pseudoprogression and pseudoresponse: Challenges in brain tumor imaging
    • Review
    • Clarke JL, Chang S. Pseudoprogression and pseudoresponse: challenges in brain tumor imaging. Curr Neurol Neurosci Rep. 2009;9(3):241-246. Review.
    • (2009) Curr Neurol Neurosci Rep , vol.9 , Issue.3 , pp. 241-246
    • Clarke, J.L.1    Chang, S.2
  • 8
    • 74049087788 scopus 로고    scopus 로고
    • Pseudoprogression and pseudoresponse in the treatment of gliomas
    • Brandsma D, van den Bent MJ. Pseudoprogression and pseudoresponse in the treatment of gliomas. Curr Opin Neurol. 2009;22(6): 633-638.
    • (2009) Curr Opin Neurol , vol.22 , Issue.6 , pp. 633-638
    • Brandsma, D.1    Van Den Bent, M.J.2
  • 9
    • 42649106522 scopus 로고    scopus 로고
    • Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas
    • DOI 10.1016/S1470-2045(08)70125-6, PII S1470204508701256
    • Brandsma D, Stalpers L, Taal W, et al. Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas. Lancet Oncol. 2008;9(5):453-461. (Pubitemid 351597795)
    • (2008) The Lancet Oncology , vol.9 , Issue.5 , pp. 453-461
    • Brandsma, D.1    Stalpers, L.2    Taal, W.3    Sminia, P.4    Van Den Bent, M.J.5
  • 10
    • 43749094544 scopus 로고    scopus 로고
    • MGMT promoter methylation status can predict the incidence and outcome of pseudoprogression after concomitant radiochemotherapy in newly diagnosed glioblastoma patients
    • Brandes AA, Franceschi E, Tosoni A, et al. MGMT promoter methylation status can predict the incidence and outcome of pseudoprogression after concomitant radiochemotherapy in newly diagnosed glioblastoma patients. J Clin Oncol. 2008;26(13):2192-2197.
    • (2008) J Clin Oncol , vol.26 , Issue.13 , pp. 2192-2197
    • Brandes, A.A.1    Franceschi, E.2    Tosoni, A.3
  • 11
    • 0018633855 scopus 로고
    • The morphologic effects of radiation administered therapeutically for intracranial gliomas. A postmortem study of 25 cases
    • DOI 10.1002/1097-0142(197910)44:4<1256::AID-CNCR2820440415>3.0. CO;2-T
    • Burger PC, Mahley MS, Jr, Dudka L, Vogel FS. The morphologic effects of radiation administered therapeutically for intracranial gliomas: a postmortem study of 25 cases. Cancer. 1979;44(4): 1256-1272. (Pubitemid 10197395)
    • (1979) Cancer , vol.44 , Issue.4 , pp. 1256-1272
    • Burger, P.C.1    Mahaley Jr., M.S.2    Dudka, L.3    Vogel, F.S.4
  • 12
    • 0028939011 scopus 로고
    • Radiation necrosis or glioma recurrence: Is computer-assisted stereotactic biopsy useful?
    • Forsyth PA, Kelly PJ, Cascino TL, et al. Radiation necrosis or glioma recurrence: is computer-assisted stereotactic biopsy useful? J Neurosurg. 1995;82(3):436-444.
    • (1995) J Neurosurg , vol.82 , Issue.3 , pp. 436-444
    • Forsyth, P.A.1    Kelly, P.J.2    Cascino, T.L.3
  • 13
    • 33645575773 scopus 로고    scopus 로고
    • Cancer therapy-associated CNS neuropathology: An update and review of the literature
    • Perry A, Schmidt RE. Cancer therapy-associated CNS neuropathology: an update and review of the literature. Acta Neuropathol. 2006; 111(3):197-212.
    • (2006) Acta Neuropathol , vol.111 , Issue.3 , pp. 197-212
    • Perry, A.1    Schmidt, R.E.2
  • 14
    • 84859098891 scopus 로고    scopus 로고
    • Pathologic diagnosis of recurrent glioblastoma: Morphologic, immunohistochemical, and molecular analysis of 20 paired cases
    • Kim JH, Kim YB, Han JH, et al. Pathologic Diagnosis of Recurrent Glioblastoma: Morphologic, Immunohistochemical, and Molecular Analysis of 20 Paired Cases. Am J Surg Pathol. 2012;36(4):620-628.
    • (2012) Am J Surg Pathol. , vol.36 , Issue.4 , pp. 620-628
    • Kim, J.H.1    Kim, Y.B.2    Han, J.H.3
  • 15
    • 33244476044 scopus 로고    scopus 로고
    • Prognostic value of detecting recurrent glioblastoma multiforme in surgical specimens from patients after radiotherapy: Should pathology evaluation alter treatment decisions?
    • DOI 10.1016/j.humpath.2005.11.010, PII S004681770500657X
    • Tihan T, Barletta J, Parney I, et al. Prognostic value of detecting recurrent glioblastoma multiforme in surgical specimens from patients after radiotherapy: should pathology evaluation alter treatment decisions? Hum Pathol. 2006;37(3):272-282. (Pubitemid 43277515)
    • (2006) Human Pathology , vol.37 , Issue.3 , pp. 272-282
    • Tihan, T.1    Barletta, J.2    Parney, I.3    Lamborn, K.4    Sneed, P.K.5    Chang, S.6
  • 16
    • 76749097367 scopus 로고    scopus 로고
    • Differentiation of recurrent glioblastoma multiforme from radiation necrosis after external beam radiation therapy with dynamic susceptibility- weighted contrast-enhanced perfusion MR imaging
    • Barajas RF, Jr, Chang JS, Segal MR, et al. Differentiation of recurrent glioblastoma multiforme from radiation necrosis after external beam radiation therapy with dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging. Radiology. 2009;253(2): 486-496.
    • (2009) Radiology , vol.253 , Issue.2 , pp. 486-496
    • Barajas Jr., R.F.1    Chang, J.S.2    Segal, M.R.3
  • 17
    • 0034064281 scopus 로고    scopus 로고
    • Posttherapeutic intraaxial brain tumor: The value of perfusion-sensitive contrast-enhanced MR imaging for differentiating tumor recurrence from nonneoplastic contrast-enhancing tissue
    • Sugahara T, Korogi Y, Tomiguchi S, et al. Posttherapeutic intraaxial brain tumor: the value of perfusion-sensitive contrast-enhanced MR imaging for differentiating tumor recurrence from nonneoplastic contrastenhancing tissue. AJNR Am J Neuroradiol. 2000;21(5):901-909. (Pubitemid 30262837)
    • (2000) American Journal of Neuroradiology , vol.21 , Issue.5 , pp. 901-909
    • Sugahara, T.1    Korogi, Y.2    Tomiguchi, S.3    Shigematsu, Y.4    Ikushima, I.5    Kira, T.6    Liang, L.7    Ushio, Y.8    Takahashi, M.9
  • 18
    • 77956132723 scopus 로고    scopus 로고
    • Posttreatment high-grade glioma: Usefulness of peak height position with semiquantitative MR perfusion histogram analysis in an entire contrast-enhanced lesion for predicting volume fraction of recurrence
    • Kim HS, Kim JH, Kim SH, et al. Posttreatment high-grade glioma: usefulness of peak height position with semiquantitative MR perfusion histogram analysis in an entire contrast-enhanced lesion for predicting volume fraction of recurrence. Radiology. 2010; 256(3):906-915.
    • (2010) Radiology. , vol.256 , Issue.3 , pp. 906-915
    • Kim, H.S.1    Kim, J.H.2    Kim, S.H.3
  • 19
    • 45149091277 scopus 로고    scopus 로고
    • Glioma grading by using histogram analysis of blood volume heterogeneity from MR-derived cerebral blood volume maps
    • Emblem KE, Nedregaard B, Nome T, et al. Glioma grading by using histogram analysis of blood volume heterogeneity from MR-derived cerebral blood volume maps. Radiology. 2008;247(3):808-817.
    • (2008) Radiology , vol.247 , Issue.3 , pp. 808-817
    • Emblem, K.E.1    Nedregaard, B.2    Nome, T.3
  • 20
    • 62649103363 scopus 로고    scopus 로고
    • Posttreatment recurrence of malignant brain neoplasm: Accuracy of relative cerebral blood volume fraction in discriminating low from high malignant histologic volume fraction
    • Gasparetto EL, Pawlak MA, Patel SH, et al. Posttreatment recurrence of malignant brain neoplasm: accuracy of relative cerebral blood volume fraction in discriminating low from high malignant histologic volume fraction. Radiology. 2009;250(3):887-896.
    • (2009) Radiology , vol.250 , Issue.3 , pp. 887-896
    • Gasparetto, E.L.1    Pawlak, M.A.2    Patel, S.H.3
  • 21
    • 64649101485 scopus 로고    scopus 로고
    • Relative cerebral blood volume values to differentiate high-grade glioma recurrence from posttreatment radiation effect: Direct correlation between image-guided tissue histopathology and localized dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging measurements
    • Hu LS, Baxter LC, Smith KA, et al. Relative cerebral blood volume values to differentiate high-grade glioma recurrence from posttreatment radiation effect: direct correlation between image-guided tissue histopathology and localized dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging measurements. AJNR Am J Neuroradiol. 2009;30(3):552-558.
    • (2009) AJNR Am J Neuroradiol , vol.30 , Issue.3 , pp. 552-558
    • Hu, L.S.1    Baxter, L.C.2    Smith, K.A.3
  • 22
    • 33748084051 scopus 로고    scopus 로고
    • Relative cerebral blood volume maps corrected for contrast agent extravasation significantly correlate with glioma tumor grade, whereas uncorrected maps do not
    • Boxerman JL, Schmainda KM, Weisskoff RM. Relative cerebral blood volume maps corrected for contrast agent extravasation significantly correlate with glioma tumor grade, whereas uncorrected maps do not. AJNR Am J Neuroradiol. 2006;27(4):859-867. (Pubitemid 44897737)
    • (2006) American Journal of Neuroradiology , vol.27 , Issue.4 , pp. 859-867
    • Boxerman, J.L.1    Schmainda, K.M.2    Weisskoff, R.M.3
  • 23
    • 56149097774 scopus 로고    scopus 로고
    • Comparison of dynamic susceptibilityweighted contrast-enhanced MR methods: Recommendations for measuring relative cerebral blood volume in brain tumors
    • Paulson ES, Schmainda KM. Comparison of dynamic susceptibilityweighted contrast-enhanced MR methods: recommendations for measuring relative cerebral blood volume in brain tumors. Radiology. 2008;249(2):601-613.
    • (2008) Radiology , vol.249 , Issue.2 , pp. 601-613
    • Paulson, E.S.1    Schmainda, K.M.2
  • 24
    • 75749125421 scopus 로고    scopus 로고
    • Optimized preload leakagecorrection methods to improve the diagnostic accuracy of dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging in posttreatment gliomas
    • Hu LS, Baxter LC, Pinnaduwage DS, et al. Optimized preload leakagecorrection methods to improve the diagnostic accuracy of dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging in posttreatment gliomas. AJNR Am J Neuroradiol. 2010;31(1):40-48.
    • (2010) AJNR Am J Neuroradiol. , vol.31 , Issue.1 , pp. 40-48
    • Hu, L.S.1    Baxter, L.C.2    Pinnaduwage, D.S.3
  • 25
    • 0033950756 scopus 로고    scopus 로고
    • Abnormalities of the contrast re-circulation phase in cerebral tumors demonstrated using dynamic susceptibility contrast-enhanced imaging: A possible marker of vascular tortuosity
    • DOI 10.1002/(SICI)1522-2586(200002)11:2<103::AID-JMRI5>3.0.CO;2-Z
    • Kassner A, Annesley DJ, Zhu XP, et al. Abnormalities of the contrast recirculation phase in cerebral tumors demonstrated using dynamic susceptibility contrast-enhanced imaging: a possible marker of vascular tortuosity. J Magn Reson Imaging. 2000;11(2):103-113. (Pubitemid 30080962)
    • (2000) Journal of Magnetic Resonance Imaging , vol.11 , Issue.2 , pp. 103-113
    • Kassner, A.1    Annesley, D.J.2    Zhu, X.P.3    Li, K.L.4    Kamaly-Asl, I.D.5    Watson, Y.6    Jackson, A.7
  • 26
    • 84862835110 scopus 로고    scopus 로고
    • World Health Organization 4th ed. Geneva, Switzerland: World Health
    • World Health Organization. ICD-O:WHO Classification of Tumors, 4th ed. Geneva, Switzerland: World Health; 2006.
    • (2006) ICD-O:WHO Classification of Tumors
  • 27
    • 0036820488 scopus 로고    scopus 로고
    • Correlations between magnetic resonance spectroscopy and image-guided histopathology, with special attention to radiation necrosis
    • discussion 919-20
    • Rock JP, Hearshen D, Scarpace L, et al. Correlations between magnetic resonance spectroscopy and image-guided histopathology, with special attention to radiation necrosis. Neurosurgery. 2002;51(4):912-919; discussion 919-20.
    • (2002) Neurosurgery , vol.51 , Issue.4 , pp. 912-919
    • Rock, J.P.1    Hearshen, D.2    Scarpace, L.3
  • 28
    • 2342576838 scopus 로고    scopus 로고
    • Associations among magnetic resonance spectroscopy, apparent diffusion coefficients, and imageguided histopathology with special attention to radiation necrosis
    • discussion 1117-9
    • Rock JP, Scarpace L, Hearshen D, et al. Associations among magnetic resonance spectroscopy, apparent diffusion coefficients, and imageguided histopathology with special attention to radiation necrosis. Neurosurgery. 2004;54(5):1111-1117; discussion 1117-9.
    • (2004) Neurosurgery , vol.54 , Issue.5 , pp. 1111-1117
    • Rock, J.P.1    Scarpace, L.2    Hearshen, D.3
  • 29
    • 0037222645 scopus 로고    scopus 로고
    • Prognostic value of magnetic resonance imaging-guided stereotactic biopsy in the evaluation of recurrent malignant astrocytoma compared with a lesion due to radiation effect
    • McGirt MJ, Bulsara KR, Cummings TJ, et al. Prognostic value of magnetic resonance imaging-guided stereotactic biopsy in the evaluation of recurrent malignant astrocytoma compared with a lesion due to radiation effect. J Neurosurg. 2003;98(1):14-20. (Pubitemid 36050442)
    • (2003) Journal of Neurosurgery , vol.98 , Issue.1 SUPPL. , pp. 14-20
    • McGirt, M.J.1    Bulsara, K.R.2    Cummings, T.J.3    New, K.C.4    Little, K.M.5    Friedman, H.S.6    Friedman, A.H.7
  • 30
    • 27944474903 scopus 로고    scopus 로고
    • Dynamic susceptibility-weighted perfusion imaging of high-grade gliomas: Characterization of spatial heterogeneity
    • Lupo JM, Cha S, Chang SM, Nelson SJ. Dynamic susceptibility-weighted perfusion imaging of high-grade gliomas: characterization of spatial heterogeneity. AJNR Am J Neuroradiol. 2005;26(6):1446-1454. (Pubitemid 43733445)
    • (2005) American Journal of Neuroradiology , vol.26 , Issue.6 , pp. 1446-1454
    • Lupo, J.M.1    Cha, S.2    Chang, S.M.3    Nelson, S.J.4
  • 31
    • 0027992961 scopus 로고
    • Quantitative immunohistological analysis of the microvasculature in untreated human glioblastoma multiforme. Computer-assisted image analysis of whole-tumor sections
    • Wesseling P, van der Laak JA, de Leeuw H, et al. Quantitative immunohistological analysis of the microvasculature in untreated human glioblastoma multiforme. Computer-assisted image analysis of whole-tumor sections. J Neurosurg. 1994;81(6):902-909. (Pubitemid 24373471)
    • (1994) Journal of Neurosurgery , vol.81 , Issue.6 , pp. 902-909
    • Wesseling, P.1    Van Der Laak, J.A.2    De Leeuw, H.3    Ruiter, D.J.4    Burger, P.C.5
  • 33
    • 84862908602 scopus 로고    scopus 로고
    • Correlations between perfusion MR imaging cerebral blood volume, microvessel quantification, and clinical outcome using stereotactic analysis in recurrent high-grade glioma
    • Hu LS, Eschbacher JM, Dueck AC, et al. Correlations between perfusion MR imaging cerebral blood volume, microvessel quantification, and clinical outcome using stereotactic analysis in recurrent high-grade glioma. AJNR Am J Neuroradiol. 2012;33(1):69-76.
    • (2012) AJNR Am J Neuroradiol. , vol.33 , Issue.1 , pp. 69-76
    • Hu, L.S.1    Eschbacher, J.M.2    Dueck, A.C.3
  • 34
    • 77955128785 scopus 로고    scopus 로고
    • Changes in relative cerebral blood volume 1 month after radiation-temozolomide therapy can help predict overall survival in patients with glioblastoma
    • Mangla R, Singh G, Ziegelitz D, et al. Changes in relative cerebral blood volume 1 month after radiation-temozolomide therapy can help predict overall survival in patients with glioblastoma. Radiology. 2010;256(2): 575-584.
    • (2010) Radiology. , vol.256 , Issue.2 , pp. 575-584
    • Mangla, R.1    Singh, G.2    Ziegelitz, D.3
  • 35
    • 79960411354 scopus 로고    scopus 로고
    • Prospective analysis of parametric response map-derived MRI biomarkers: Identification of early and distinct glioma response patterns not predicted by standard radiographic assessment
    • Galbá n CJ, Chenevert TL, Meyer CR, et al. Prospective analysis of parametric response map-derived MRI biomarkers: identification of early and distinct glioma response patterns not predicted by standard radiographic assessment. Clin Cancer Res. 2011;17(14):4751-4760.
    • (2011) Clin Cancer Res. , vol.17 , Issue.14 , pp. 4751-4760
    • Galbán Cj, C.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.